Insulin-like growth factor (IGF) axis in cancerogenesis
A Kasprzak, W Kwasniewski, A Adamek… - … Research/Reviews in …, 2017 - Elsevier
Determination of the role of insulin-like growth factor (IGF) family components in
carcinogenesis of several human tumors is based on numerous epidemiological and pre …
carcinogenesis of several human tumors is based on numerous epidemiological and pre …
[HTML][HTML] Mechanism and recent updates on insulin-related disorders
S Kumar, S Senapati, N Bhattacharya… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Insulin, a small protein with 51 amino acids synthesized by pancreatic β-cells, is crucial to
sustain glucose homeostasis at biochemical and molecular levels. Numerous metabolic …
sustain glucose homeostasis at biochemical and molecular levels. Numerous metabolic …
Notch transduction in non-small cell lung cancer
A Sharif, A Shaji, M Chammaa, E Pawlik… - International Journal of …, 2020 - mdpi.com
The evolutionarily-conserved Notch signaling pathway plays critical roles in cell
communication, function and homeostasis equilibrium. The pathway serves as a cell-to-cell …
communication, function and homeostasis equilibrium. The pathway serves as a cell-to-cell …
Let-7b-5p regulates proliferation and apoptosis in multiple myeloma by targeting IGF1R
H Xu, C Liu, Y Zhang, X Guo, Z Liu, Z Luo… - Acta Biochim …, 2014 - academic.oup.com
Multiple myeloma (MM) is the most common cause of death from hematological malignancy
worldwide, and recent studies have revealed that let-7b-5p can play an inhibitory role in …
worldwide, and recent studies have revealed that let-7b-5p can play an inhibitory role in …
Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells
Non‐small cell lung cancer (NSCLC) patients with an epidermal growth factor receptor
(EGFR) mutation have benefited from treatment of reversible EGFR tyrosine kinase inhibitors …
(EGFR) mutation have benefited from treatment of reversible EGFR tyrosine kinase inhibitors …
Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
Z Huang, M Zhang, G Chen… - International …, 2019 - spandidos-publications.com
Although important progress has been made in elucidating the role of the tumor
microenvironment in the development of bladder cancer, little is currently known regarding …
microenvironment in the development of bladder cancer, little is currently known regarding …
Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer
F Wang, F Meng, SCC Wong… - Therapeutic …, 2020 - journals.sagepub.com
Background: Non-small cell lung cancer (NSCLC) patients with an epidermal growth factor
receptor (EGFR) mutation often initially respond to EGFR tyrosine kinase inhibitor (EGFR …
receptor (EGFR) mutation often initially respond to EGFR tyrosine kinase inhibitor (EGFR …
Inhibition of COX-2 and EGFR by melafolone improves anti-PD-1 therapy through vascular normalization and PD-L1 downregulation in lung cancer
H Tang, Y Liu, C Wang, H Zheng, Y Chen, W Liu… - … of Pharmacology and …, 2019 - ASPET
Checkpoint blockade therapy has been proven efficacious in lung cancer patients. However,
primary/acquired resistance hampers its efficacy. Therefore, there is an urgent need to …
primary/acquired resistance hampers its efficacy. Therefore, there is an urgent need to …
Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in …
L Chao, H Yi-Sheng, C Yu, Y Li-Xu, L Xin-Lan… - Lung cancer, 2014 - Elsevier
Background A new histological classification by the International Association for the Study of
Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) …
Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) …
Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)
AJ Piper, JL Clark, J Mercado-Matos… - PloS one, 2019 - journals.plos.org
The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small
cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is …
cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is …